Lv2
178 积分 2024-06-21 加入
Phase Ib/II dose expansion study of lenvatinib combined with letrozole in post-menopausal women with hormone receptor positive breast cancer
7天前
已完结
Clinical Activity of RET Tyrosine Kinase Inhibitor (TKI) plus Chemotherapy after Progression on a RET TKI in a RET Fusion–Positive Non–Small Cell Lung Cancer Real-World Cohort: A Brief Report
1个月前
已关闭
Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA -mutant breast cancer
1个月前
已完结
Pharmacologic Features, Clinical Applications, and Drug Safety Evaluation of Inavolisib in the Treatment of Metastatic Breast Cancer
1个月前
已完结
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer
1个月前
已完结
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
1个月前
已完结
RET receptor tyrosine kinase promotes breast cancer metastasis to the brain and RET inhibitors pralsetinib and selpercatinib suppress breast cancer brain metastases
1个月前
已完结
Targeted Therapies for Breast Cancer Brain Metastases
1个月前
已关闭
Ret Receptor Has Distinct Alterations and Functions in Breast Cancer
2个月前
已完结
RET in breast cancer: functional and therapeutic implications
2个月前
已完结
皖公网安备34019202002308
